STATIN-FIBRATE REPORT: Focus on Safety

In the World Health Organization (WHO) Cooperative Trial, 15,745 males without coronary artery disease were enrolled and followed for a mean of 5.3 years.81 Serum cholesterol was measured in 30,000 volunteers and 10,000 of those patients, in the upper third distribution of serum cholesterol concentrations, were randomized to receive clofibrate ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.